The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sickle Cell Anemia Testing & Screening Market Research Report 2025
Synopsis
Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of Sickle Cell Disease.
The global Sickle Cell Anemia Testing & Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Anemia Testing & Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Anemia Testing & Screening.
Report Scope
The Sickle Cell Anemia Testing & Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sickle Cell Anemia Testing & Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Anemia Testing & Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STRECK, INC.
BioMedomics Inc.
Laboratory Corporation of America Holdings
Silver Lake Research Corporation
HEMEX HEALTH
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Quest Diagnostics
Segment by Type
Hemoglobin Electrophoresis
High-performance Liquid Chromatography (HPLC)
Point-of-Care Tests
Other Tests
Segment by Application
Newborn Screening (12 months and below)
Adult Screening (25 to 60 years)
Other Age Groups (1 to 25 & above 60 years)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Anemia Testing & Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of Sickle Cell Disease.
The global Sickle Cell Anemia Testing & Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Anemia Testing & Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Anemia Testing & Screening.
Report Scope
The Sickle Cell Anemia Testing & Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sickle Cell Anemia Testing & Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Anemia Testing & Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STRECK, INC.
BioMedomics Inc.
Laboratory Corporation of America Holdings
Silver Lake Research Corporation
HEMEX HEALTH
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Quest Diagnostics
Segment by Type
Hemoglobin Electrophoresis
High-performance Liquid Chromatography (HPLC)
Point-of-Care Tests
Other Tests
Segment by Application
Newborn Screening (12 months and below)
Adult Screening (25 to 60 years)
Other Age Groups (1 to 25 & above 60 years)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Anemia Testing & Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemoglobin Electrophoresis
1.2.3 High-performance Liquid Chromatography (HPLC)
1.2.4 Point-of-Care Tests
1.2.5 Other Tests
1.3 Market by Application
1.3.1 Global Sickle Cell Anemia Testing & Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Newborn Screening (12 months and below)
1.3.3 Adult Screening (25 to 60 years)
1.3.4 Other Age Groups (1 to 25 & above 60 years)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Anemia Testing & Screening Market Perspective (2019-2030)
2.2 Sickle Cell Anemia Testing & Screening Growth Trends by Region
2.2.1 Global Sickle Cell Anemia Testing & Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sickle Cell Anemia Testing & Screening Historic Market Size by Region (2019-2024)
2.2.3 Sickle Cell Anemia Testing & Screening Forecasted Market Size by Region (2025-2030)
2.3 Sickle Cell Anemia Testing & Screening Market Dynamics
2.3.1 Sickle Cell Anemia Testing & Screening Industry Trends
2.3.2 Sickle Cell Anemia Testing & Screening Market Drivers
2.3.3 Sickle Cell Anemia Testing & Screening Market Challenges
2.3.4 Sickle Cell Anemia Testing & Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Anemia Testing & Screening Players by Revenue
3.1.1 Global Top Sickle Cell Anemia Testing & Screening Players by Revenue (2019-2024)
3.1.2 Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Players (2019-2024)
3.2 Global Sickle Cell Anemia Testing & Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Anemia Testing & Screening Revenue
3.4 Global Sickle Cell Anemia Testing & Screening Market Concentration Ratio
3.4.1 Global Sickle Cell Anemia Testing & Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Testing & Screening Revenue in 2023
3.5 Sickle Cell Anemia Testing & Screening Key Players Head office and Area Served
3.6 Key Players Sickle Cell Anemia Testing & Screening Product Solution and Service
3.7 Date of Enter into Sickle Cell Anemia Testing & Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Anemia Testing & Screening Breakdown Data by Type
4.1 Global Sickle Cell Anemia Testing & Screening Historic Market Size by Type (2019-2024)
4.2 Global Sickle Cell Anemia Testing & Screening Forecasted Market Size by Type (2025-2030)
5 Sickle Cell Anemia Testing & Screening Breakdown Data by Application
5.1 Global Sickle Cell Anemia Testing & Screening Historic Market Size by Application (2019-2024)
5.2 Global Sickle Cell Anemia Testing & Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sickle Cell Anemia Testing & Screening Market Size (2019-2030)
6.2 North America Sickle Cell Anemia Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024)
6.4 North America Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Anemia Testing & Screening Market Size (2019-2030)
7.2 Europe Sickle Cell Anemia Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024)
7.4 Europe Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size (2019-2030)
8.2 Asia-Pacific Sickle Cell Anemia Testing & Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Anemia Testing & Screening Market Size (2019-2030)
9.2 Latin America Sickle Cell Anemia Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024)
9.4 Latin America Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size (2019-2030)
10.2 Middle East & Africa Sickle Cell Anemia Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STRECK, INC.
11.1.1 STRECK, INC. Company Detail
11.1.2 STRECK, INC. Business Overview
11.1.3 STRECK, INC. Sickle Cell Anemia Testing & Screening Introduction
11.1.4 STRECK, INC. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.1.5 STRECK, INC. Recent Development
11.2 BioMedomics Inc.
11.2.1 BioMedomics Inc. Company Detail
11.2.2 BioMedomics Inc. Business Overview
11.2.3 BioMedomics Inc. Sickle Cell Anemia Testing & Screening Introduction
11.2.4 BioMedomics Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.2.5 BioMedomics Inc. Recent Development
11.3 Laboratory Corporation of America Holdings
11.3.1 Laboratory Corporation of America Holdings Company Detail
11.3.2 Laboratory Corporation of America Holdings Business Overview
11.3.3 Laboratory Corporation of America Holdings Sickle Cell Anemia Testing & Screening Introduction
11.3.4 Laboratory Corporation of America Holdings Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.3.5 Laboratory Corporation of America Holdings Recent Development
11.4 Silver Lake Research Corporation
11.4.1 Silver Lake Research Corporation Company Detail
11.4.2 Silver Lake Research Corporation Business Overview
11.4.3 Silver Lake Research Corporation Sickle Cell Anemia Testing & Screening Introduction
11.4.4 Silver Lake Research Corporation Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.4.5 Silver Lake Research Corporation Recent Development
11.5 HEMEX HEALTH
11.5.1 HEMEX HEALTH Company Detail
11.5.2 HEMEX HEALTH Business Overview
11.5.3 HEMEX HEALTH Sickle Cell Anemia Testing & Screening Introduction
11.5.4 HEMEX HEALTH Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.5.5 HEMEX HEALTH Recent Development
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Detail
11.6.2 Bio-Rad Laboratories, Inc. Business Overview
11.6.3 Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing & Screening Introduction
11.6.4 Bio-Rad Laboratories, Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.6.5 Bio-Rad Laboratories, Inc. Recent Development
11.7 PerkinElmer Inc.
11.7.1 PerkinElmer Inc. Company Detail
11.7.2 PerkinElmer Inc. Business Overview
11.7.3 PerkinElmer Inc. Sickle Cell Anemia Testing & Screening Introduction
11.7.4 PerkinElmer Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.7.5 PerkinElmer Inc. Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Sickle Cell Anemia Testing & Screening Introduction
11.8.4 Quest Diagnostics Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024)
11.8.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hemoglobin Electrophoresis
Table 3. Key Players of High-performance Liquid Chromatography (HPLC)
Table 4. Key Players of Point-of-Care Tests
Table 5. Key Players of Other Tests
Table 6. Global Sickle Cell Anemia Testing & Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Sickle Cell Anemia Testing & Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Sickle Cell Anemia Testing & Screening Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Sickle Cell Anemia Testing & Screening Market Share by Region (2019-2024)
Table 10. Global Sickle Cell Anemia Testing & Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Sickle Cell Anemia Testing & Screening Market Share by Region (2025-2030)
Table 12. Sickle Cell Anemia Testing & Screening Market Trends
Table 13. Sickle Cell Anemia Testing & Screening Market Drivers
Table 14. Sickle Cell Anemia Testing & Screening Market Challenges
Table 15. Sickle Cell Anemia Testing & Screening Market Restraints
Table 16. Global Sickle Cell Anemia Testing & Screening Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Sickle Cell Anemia Testing & Screening Market Share by Players (2019-2024)
Table 18. Global Top Sickle Cell Anemia Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Testing & Screening as of 2023)
Table 19. Ranking of Global Top Sickle Cell Anemia Testing & Screening Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Sickle Cell Anemia Testing & Screening Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sickle Cell Anemia Testing & Screening Product Solution and Service
Table 23. Date of Enter into Sickle Cell Anemia Testing & Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sickle Cell Anemia Testing & Screening Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Type (2019-2024)
Table 27. Global Sickle Cell Anemia Testing & Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Type (2025-2030)
Table 29. Global Sickle Cell Anemia Testing & Screening Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Application (2019-2024)
Table 31. Global Sickle Cell Anemia Testing & Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Application (2025-2030)
Table 33. North America Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size by Country (2025-2030) & (US$ Million)
Table 48. STRECK, INC. Company Detail
Table 49. STRECK, INC. Business Overview
Table 50. STRECK, INC. Sickle Cell Anemia Testing & Screening Product
Table 51. STRECK, INC. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 52. STRECK, INC. Recent Development
Table 53. BioMedomics Inc. Company Detail
Table 54. BioMedomics Inc. Business Overview
Table 55. BioMedomics Inc. Sickle Cell Anemia Testing & Screening Product
Table 56. BioMedomics Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 57. BioMedomics Inc. Recent Development
Table 58. Laboratory Corporation of America Holdings Company Detail
Table 59. Laboratory Corporation of America Holdings Business Overview
Table 60. Laboratory Corporation of America Holdings Sickle Cell Anemia Testing & Screening Product
Table 61. Laboratory Corporation of America Holdings Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 62. Laboratory Corporation of America Holdings Recent Development
Table 63. Silver Lake Research Corporation Company Detail
Table 64. Silver Lake Research Corporation Business Overview
Table 65. Silver Lake Research Corporation Sickle Cell Anemia Testing & Screening Product
Table 66. Silver Lake Research Corporation Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 67. Silver Lake Research Corporation Recent Development
Table 68. HEMEX HEALTH Company Detail
Table 69. HEMEX HEALTH Business Overview
Table 70. HEMEX HEALTH Sickle Cell Anemia Testing & Screening Product
Table 71. HEMEX HEALTH Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 72. HEMEX HEALTH Recent Development
Table 73. Bio-Rad Laboratories, Inc. Company Detail
Table 74. Bio-Rad Laboratories, Inc. Business Overview
Table 75. Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing & Screening Product
Table 76. Bio-Rad Laboratories, Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 77. Bio-Rad Laboratories, Inc. Recent Development
Table 78. PerkinElmer Inc. Company Detail
Table 79. PerkinElmer Inc. Business Overview
Table 80. PerkinElmer Inc. Sickle Cell Anemia Testing & Screening Product
Table 81. PerkinElmer Inc. Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 82. PerkinElmer Inc. Recent Development
Table 83. Quest Diagnostics Company Detail
Table 84. Quest Diagnostics Business Overview
Table 85. Quest Diagnostics Sickle Cell Anemia Testing & Screening Product
Table 86. Quest Diagnostics Revenue in Sickle Cell Anemia Testing & Screening Business (2019-2024) & (US$ Million)
Table 87. Quest Diagnostics Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Anemia Testing & Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sickle Cell Anemia Testing & Screening Market Share by Type: 2023 VS 2030
Figure 3. Hemoglobin Electrophoresis Features
Figure 4. High-performance Liquid Chromatography (HPLC) Features
Figure 5. Point-of-Care Tests Features
Figure 6. Other Tests Features
Figure 7. Global Sickle Cell Anemia Testing & Screening Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sickle Cell Anemia Testing & Screening Market Share by Application: 2023 VS 2030
Figure 9. Newborn Screening (12 months and below) Case Studies
Figure 10. Adult Screening (25 to 60 years) Case Studies
Figure 11. Other Age Groups (1 to 25 & above 60 years) Case Studies
Figure 12. Sickle Cell Anemia Testing & Screening Report Years Considered
Figure 13. Global Sickle Cell Anemia Testing & Screening Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Sickle Cell Anemia Testing & Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Sickle Cell Anemia Testing & Screening Market Share by Region: 2023 VS 2030
Figure 16. Global Sickle Cell Anemia Testing & Screening Market Share by Players in 2023
Figure 17. Global Top Sickle Cell Anemia Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Testing & Screening as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Testing & Screening Revenue in 2023
Figure 19. North America Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Sickle Cell Anemia Testing & Screening Market Share by Country (2019-2030)
Figure 21. United States Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Sickle Cell Anemia Testing & Screening Market Share by Country (2019-2030)
Figure 25. Germany Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Sickle Cell Anemia Testing & Screening Market Share by Region (2019-2030)
Figure 33. China Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Sickle Cell Anemia Testing & Screening Market Share by Country (2019-2030)
Figure 41. Mexico Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Sickle Cell Anemia Testing & Screening Market Share by Country (2019-2030)
Figure 45. Turkey Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. STRECK, INC. Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 48. BioMedomics Inc. Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 49. Laboratory Corporation of America Holdings Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 50. Silver Lake Research Corporation Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 51. HEMEX HEALTH Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 53. PerkinElmer Inc. Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 54. Quest Diagnostics Revenue Growth Rate in Sickle Cell Anemia Testing & Screening Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
